Outcomes of Tuberculosis Treatment and Contributing Factors Among Patients Receiving Anti-TB Therapy in Public Health Facilities of Nekemte, Oromia Region, Western Ethiopia - Scorecard - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Outcomes of Tuberculosis Treatment and Contributing Factors Among Patients Receiving Anti-TB Therapy in Public Health Facilities of Nekemte, Oromia Region, Western Ethiopia
Clinical Scorecard: Outcomes of Tuberculosis Treatment and Contributing Factors Among Patients Receiving Anti-TB Therapy in Public Health Facilities of Nekemte, Oromia Region, Western Ethiopia
At a Glance
Category
Detail
Condition
Tuberculosis (TB)
Key Mechanisms
Caused by Mycobacterium tuberculosis, primarily affecting the lungs.
Target Population
Adults and children receiving TB treatment in public health facilities.
Care Setting
Public health facilities in Nekemte, Ethiopia.
Key Highlights
Ethiopia has implemented DOTS since 1990, achieving 100% geographic coverage.
Shorter, all-oral regimens for drug-resistant TB have improved treatment outcomes.
The international TB treatment success rate is 83%, with Africa at 79%.
Social and economic factors significantly impact TB treatment outcomes.
A total of 800 patient records were analyzed for treatment outcomes.
Guideline-Based Recommendations
Diagnosis
Early identification of TB through effective screening and diagnostic methods.
Management
Utilization of DOTS and all-oral regimens for TB treatment.
Monitoring & Follow-up
Routine monitoring of treatment outcomes to identify and address system flaws.
Risks
Social and economic factors that complicate TB prevention and treatment.
Patient & Prescribing Data
Adults over 18 years receiving DOTS treatment.
Successful treatment outcomes are linked to adherence to DOTS and effective management strategies.
Clinical Best Practices
Ensure adherence to DOTS for all patients.
Implement regular follow-ups and monitoring of treatment progress.
Address social determinants affecting TB treatment outcomes.
Study found species-specific differences in biofilm -forming capacity and antimicrobial susceptibility among supragingival bacterial isolates from patients with active dental caries.
